Sunday, December 17, 2017

Antibody Treatment For Myasthenia Gravis From Argenx Proves Effective

A Phase II proof of concept study has shown that one of Argenx’ antibodies is effective in treating the neuromuscular disease myasthenia gravis.

Argenx has released the results from a Phase II trial with ARGX-113 (efgartigimod), in which the antibody therapy has proved to provide a significant improvement in patients with generalized myasthenia gravis, a form of the disease that affects the strength of multiple muscles simultaneously. Argenx’ stock on Euronext Brussels is up by 24% a few hours after it opened this

Thursday, November 16, 2017

Myasthenia Gravis Symptoms Could Be Relieved By Cognitive Behavioral Therapy

Cognitive Behavioral Therapy (CBT) should be considered as a first-line treatment for myasthenia gravis (MG) patients who also suffer from anxiety, depression, or insomnia disorders, a new study urges.

The study, “Cognitive-Behavioral Therapy for Psychiatric Comorbidity in a Case of Muscle-Specific Kinase–Positive Myasthenia Gravis,” appeared in the journal The Primary Care Companion for CNS Disorders.

MG patients frequently have depression and anxiety. Medications usually help, though some patients suffer adverse events. CBT, a type of psychotherapy, can

Tuesday, November 14, 2017

Relatives Of Myasthenia Gravis Patients Have Higher Risk Of Developing The Disease

Researchers in Taiwan have found that first-degree relatives of individuals with myasthenia gravis have a higher risk of developing the disease. The risk is greater for patients’ siblings, the study found.

The study, “Familial aggregation of myasthenia gravis in affected families: a population-based study,” appeared in the journal Clinical Epidemiology.

Wednesday, October 18, 2017

MG Respiratory Failure Requires Specific Treatments in the ER, Review Contends

Myasthenic crisis is a common complication in patients with myasthenia gravis (MG), marked by exacerbation of MG symptoms and respiratory failure. But with the rarity of MG, and its similarity to a range of other neuromuscular diseases, proper detection and treatment might fail, researchers argue.

Wednesday, September 27, 2017

It Wasn't A Stroke But All The Signs Pointed That Way

“Mom?” the middle-aged man asked. He recognized the voice, but the words were muffled and strange. I’ll be right over, he said into the phone. The 15-minute drive from his small Connecticut town to his mother’s seemed to last forever. Had she had a stroke? She was 94, and though she’d always been

Friday, September 8, 2017

Vitamin D3 Deficiency Linked To Myasthenia Gravis - Study Confirms

Vitamin D From Fish Oil 

Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder. Vitamin D has important roles both in the autoimmune response and in skeletal muscles. We determined the levels of 25-hydroxy vitamin D [25(OH)D] in patients with MG and in healthy subjects to determine whether vitamin D deficiency is present in MG and whether vitamin D supplementation has beneficial effects on fatigue.

Dentistry and Myasthenia Gravis - What You and Your Dentist Need to Know

Dentistry and Myasthenia Gravis

The following article is courtesy of the Myasthenia Gravis Association of Western Pennsylvania

Dentistry can be a part of normal health care for the myasthenic and should not be feared or avoided. The objective of this article is to give both the dentist and the myasthenic a basis for understanding and communication that will result in

Friday, June 30, 2017

Outcomes After Major Surgery For Patients With Myasthenia Gravis

A couple of months ago I came close to having a total knee replacement but decided against it because of my myasthenia gravis. I just thought it was too risky. My symptoms are pretty much under control and I count myself among those MG patients that have a "relatively normal lifestyle." But I've worked hard to keep it under control and I didn't want to risk a setback. There are plenty of stories on the internet about MG patients having major surgery that worked out well and others that didn't. I just didn't want to take the chance.  

Friday, June 16, 2017

Transfusions, Surgery And Medication: Young Girl With Myasthenia Gravis Is Symptom Free

Ashley Earl-Goulet, pictured with mum Judith, has
 has recovered thanks to more than 600 blood donations
Blood from over 600 people has been used to treat a Timaru teenager with a rare auto-immune disease – and she wants the donors to know the difference it has made.

Ashley Earl-Goulet, 14, is the only child in the South Island and one of just a handful in New Zealand with myasthenia gravis, a long-term neuromuscular disease which weakens muscles – most commonly in the eyes and face.

Ashley's treatment included a blood "product" nick-named "go go juice" by health workers